Beta-adrenoceptor blocking drugs: the relevance of intrinsic sympathomimetic activity.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology*; D001986:Bronchial Spasm / Q000139:chemically induced; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D011928:Raynaud Disease / Q000139:chemically induced; D013566:Sympathomimetics / Q000494:pharmacology*
D000319:Adrenergic beta-Antagonists; D013566:Sympathomimetics